Table: Phoenixbio - 6-MTH group results
Nov 14 (Reuters)-
Phoenixbio Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2017 Sep 30, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 316 mln 557 mln 1.24
(-43.3 pct) (+1.0 pct)
Operating loss 226 mln 26 mln 52 mln
(-63.2 pct)
Recurring loss 220 mln loss 29 mln 57 mln
(-56.9 pct)
Net loss 221 mln loss 33 mln 48 mln
(-62.5 pct)
EPS loss 76.49 yen loss 11.58 yen 16.58 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Phoenixbio Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T
((Tokyo Headline News Desk +813 6441 1812))